These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1269 related articles for article (PubMed ID: 29427422)
1. Relative Abundances of Candida albicans and Candida glabrata in Olson ML; Jayaraman A; Kao KC Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29427422 [No Abstract] [Full Text] [Related]
2. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. Kucharíková S; Tournu H; Lagrou K; Van Dijck P; Bujdáková H J Med Microbiol; 2011 Sep; 60(Pt 9):1261-1269. PubMed ID: 21566087 [TBL] [Abstract][Full Text] [Related]
3. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms. Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303 [TBL] [Abstract][Full Text] [Related]
4. Influence of Candida krusei and Candida glabrata on Candida albicans gene expression in in vitro biofilms. Barros PP; Ribeiro FC; Rossoni RD; Junqueira JC; Jorge AO Arch Oral Biol; 2016 Apr; 64():92-101. PubMed ID: 26803674 [TBL] [Abstract][Full Text] [Related]
5. Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal Mohammadi F; Hemmat N; Bajalan Z; Javadi A Biomed Res Int; 2021; 2021():5598907. PubMed ID: 34136569 [TBL] [Abstract][Full Text] [Related]
6. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic. Silva S; Pires P; Monteiro DR; Negri M; Gorup LF; Camargo ER; Barbosa DB; Oliveira R; Williams DW; Henriques M; Azeredo J Med Mycol; 2013 Feb; 51(2):178-84. PubMed ID: 22803822 [TBL] [Abstract][Full Text] [Related]
7. Abundance interaction in Candida albicans and Candida glabrata mixed biofilms under diverse conditions. Li Q; Liu J; Chen M; Ma K; Wang T; Wu D; Yan G; Wang C; Shao J Med Mycol; 2021 Feb; 59(2):158-167. PubMed ID: 32453815 [TBL] [Abstract][Full Text] [Related]
8. Candida glabrata Has No Enhancing Role in the Pathogenesis of Yano J; Yu A; Fidel PL; Noverr MC mSphere; 2019 Apr; 4(2):. PubMed ID: 30944214 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm. Pesee S; Angkananuwat C; Tancharoensukjit S; Muanmai S; Sirivan P; Bubphawas M; Tanarerkchai N Med Mycol; 2016 May; 54(4):384-93. PubMed ID: 26768371 [TBL] [Abstract][Full Text] [Related]
10. Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013. Rajendran R; Sherry L; Nile CJ; Sherriff A; Johnson EM; Hanson MF; Williams C; Munro CA; Jones BJ; Ramage G Clin Microbiol Infect; 2016 Jan; 22(1):87-93. PubMed ID: 26432192 [TBL] [Abstract][Full Text] [Related]
11. The multidrug resistance transporters CgTpo1_1 and CgTpo1_2 play a role in virulence and biofilm formation in the human pathogen Candida glabrata. Santos R; Costa C; Mil-Homens D; Romão D; de Carvalho CC; Pais P; Mira NP; Fialho AM; Teixeira MC Cell Microbiol; 2017 May; 19(5):. PubMed ID: 27780306 [TBL] [Abstract][Full Text] [Related]
12. The inhibitory activity of linalool against the filamentous growth and biofilm formation in Candida albicans. Hsu CC; Lai WL; Chuang KC; Lee MH; Tsai YC Med Mycol; 2013 Jul; 51(5):473-82. PubMed ID: 23210679 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Biofilm Formation by Lee JH; Kim YG; Khadke SK; Yamano A; Watanabe A; Lee J ACS Infect Dis; 2019 Jul; 5(7):1177-1187. PubMed ID: 31055910 [No Abstract] [Full Text] [Related]
14. Susceptibility of Candida glabrata biofilms to echinocandins: alterations in the matrix composition. Rodrigues CF; Rodrigues ME; Henriques M Biofouling; 2018 May; 34(5):569-578. PubMed ID: 29798695 [TBL] [Abstract][Full Text] [Related]
15. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
16. In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model. Kucharíková S; Neirinck B; Sharma N; Vleugels J; Lagrou K; Van Dijck P J Antimicrob Chemother; 2015 Mar; 70(3):846-56. PubMed ID: 25406296 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial and anti-biofilm properties of oleuropein against Escherichia coli and fluconazole-resistant isolates of Candida albicans and Candida glabrata. Esfandiary MA; Khosravi AR; Asadi S; Nikaein D; Hassan J; Sharifzadeh A BMC Microbiol; 2024 May; 24(1):154. PubMed ID: 38704559 [TBL] [Abstract][Full Text] [Related]
18. Lab-scale preparations of Candida albicans and dual Candida albicans-Candida glabrata biofilms on the surface of medical-grade polyvinyl chloride (PVC) perfusion tube using a modified gravity-supported free-flow biofilm incubator (GS-FFBI). Shao J; Lu K; Tian G; Cui Y; Yan Y; Wang T; Zhang X; Wang C J Microbiol Methods; 2015 Feb; 109():41-8. PubMed ID: 25528294 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Candida biofilms to histatin 5 and fluconazole. Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514 [TBL] [Abstract][Full Text] [Related]
20. Divergent Approaches to Virulence in Galocha M; Pais P; Cavalheiro M; Pereira D; Viana R; Teixeira MC Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083555 [No Abstract] [Full Text] [Related] [Next] [New Search]